Atlas Trials

Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma

Clinical trial NCT02100657 · COMPLETED

Trial details

NCT number
NCT02100657
Sponsor
PharmaMar
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2014-06-01
Primary completion
2018-06-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.